Browse current and previous editions of Switzer Report
In the context of the optimistic scenarios prevailing over the pessimistic ones for at least 2026, what sexy or big upside stocks are worth considering? Here are seven, but they come with risk.
The human healthcare industry can be a frustrating place to invest but here are three examples on the ASX that are making a good fist of establishing their respective devices in world markets.
For our “HOT” stock today, Raymond Chan, Head of Asian Desk explains why Morgans regards Capstone Copper (CSC) as a BUY.
Let’s have a look at how the business is travelling, what the major brokers think, and answer the question of whether Ramsay is back in the buy zone.
For the week ending Friday, September 12, 2025, FNArena tracked thirteen upgrades and three downgrades for ASX-listed companies from brokers monitored daily.
Disappointing US economic data has underlined the nature of American investors and their commitment to being long stocks, with stocks now on a drive higher on the basis that a rate cut comes next week. It could even be a “jumbo” 50-basis points reduction!
From tech to telcos, miners to media, the duo dig into which names are buy-worthy and which ones might be running out of puff.
In our “HOT” stock article today, Michael Gable, Managing Director of Fairmont Equities, explains why Lynas Rare Earths (LYC) is a buy.
Here are three exchange traded funds (ETFs) that provide exposure to video games, esports and online betting.
Should I be worried about a rising Aussie dollar when it comes to my overseas share investments? Lonsec cut its ratings for private credit funds managed by Metric Credit Partners. Should I still invest in the Metrics Master Income Trust (MXT) unit purchase plan? Are the major brokers bullish on MediBank Private? When does CSL pay its next dividend?
With dramatic data drops raising questions about a US recession and inflation, is it time to be less confident about rising stock prices. If so, what should your defensive strategy be?
Wesfarmers (WES) has climbed all year, trading as high as $95.17 before the release of its full year result. Now the question is: Is it too expensive and a sell? Here’s what I think.
For our “HOT” stock today, Raymond Chan, Head of Asian Desk explains why Morgans regards Orica Ltd (ORI) as a BUY.
With James Dunn in the USA this week, we’re checking on our recent “HOT” stock calls. And following reporting season, do they remain hot?
For the week ending Friday 5 September 2025, FNArena tracked six upgrades and 10 downgrades for ASX-listed companies from brokers monitored daily.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.